110 related articles for article (PubMed ID: 2225856)
1. Paradoxical increased glucoheptonate uptake in experimental renovascular hypertension.
Lee HB; Gale B; Blaufox MD
Contrib Nephrol; 1990; 79():170-5. PubMed ID: 2225856
[No Abstract] [Full Text] [Related]
2. The effect of captopril on glucoheptonate uptake in experimental renal artery stenosis.
Gale B; Zhang C; Lee HB; Heller S; Blaufox MD
Nucl Med Commun; 1992 Feb; 13(2):110-3. PubMed ID: 1436896
[TBL] [Abstract][Full Text] [Related]
3. Permeability of blood vessels in experimental gliomas: uptake of 99mTc-glucoheptonate and alteration in blood-brain barrier as determined by cytochemistry and electron microscopy.
Nir I; Levanon D; Iosilevsky G
Neurosurgery; 1989 Oct; 25(4):523-31; discussion 531-2. PubMed ID: 2797390
[TBL] [Abstract][Full Text] [Related]
4. Biliary excretion of glucoheptonate.
Siegel A; Weiss D; Reilley J
Semin Nucl Med; 1992 Jan; 22(1):49-50. PubMed ID: 1589807
[No Abstract] [Full Text] [Related]
5. High sensitivity of a computerized radioisotopic method to evaluate unilateral renal blood flow reduction by first pass analysis and static imaging with 99mTc-glucoheptonate.
Fommei E; Bellina CR; Carmellini M; Palla L; Palombo C; Ghione S
J Nucl Med Allied Sci; 1983; 27(4):303-8. PubMed ID: 6325610
[No Abstract] [Full Text] [Related]
6. [A change in glomerular permeability in renovascular hypertension. Participation of angiotensin and structural lesions].
Franco M; Tapia E; Gabbai F; Cermeño JL; Calleja C; Pérez JM; Barrios R; Torres G; González FJ; Alvarado JA
Arch Inst Cardiol Mex; 1986; 56(1):13-24. PubMed ID: 2943240
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different radioactive agents for the detection of renovascular hypertension with captopril in a rat model.
McAfee JG; Kopecky RT; Thomas FD; Hellwig B; Roskopf M
J Nucl Med; 1988 Apr; 29(4):509-15. PubMed ID: 3280751
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis of renovascular hypertension with technetium-99m-ethylenedicysteine captopril scintigraphy.
Ugur O; Caner B; Cekirge S; Balkanci F; Ergün EL; Kostakoglu L; Bekdik C
Invest Radiol; 1996 Aug; 31(8):497-501. PubMed ID: 8854196
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension.
Miyamori I; Yasuhara S; Matsubara T; Takasaki H; Takeda R
Am J Hypertens; 1988 Oct; 1(4 Pt 1):359-63. PubMed ID: 3063285
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
Lee HB; Blaufox MD
J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the dose-response effects of captopril in anesthetized normotensive and renovascular hypertensive rats.
Baranes J; Thiévant P; Le Hegarat M; Delaflotte S; Etienne A; Clostre F; DeFeudis FV
Gen Pharmacol; 1982; 13(5):439-43. PubMed ID: 6757046
[TBL] [Abstract][Full Text] [Related]
12. Filtration fraction.noninvasive measurement with Tc-99m DTPA and changes induced by angiotensin-converting enzyme inhibition in hypertension.
Peters AM; George P; Brown J; Lavender JP
Nephron; 1989; 51(4):470-3. PubMed ID: 2500611
[TBL] [Abstract][Full Text] [Related]
13. Effect of captopril infusion on systemic and renal haemodynamics in conscious hypertensive rats with chronic, progressive aortic ligation.
Gonzalez-Perez LM; Martin-Paredero V; Casado S; Lopez-Novoa JM
Eur J Clin Invest; 1985 Dec; 15(6):355-9. PubMed ID: 3938404
[TBL] [Abstract][Full Text] [Related]
14. Increased brainstem angiotensin-I levels in chronic 2 KIC hypertensive rats.
Lall SB; Menon SM; Karmarkar MG; Siddiqui HH; Seth SD
Indian J Med Res; 1990 Feb; 92():43-7. PubMed ID: 2189830
[TBL] [Abstract][Full Text] [Related]
15. [Use of captopril in arterial hypertension with a stable and malignant course].
Lordkipanidze NL
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
[No Abstract] [Full Text] [Related]
16. Low-dose captopril scintigraphy in the evaluation of renovascular hypertension.
Ramirez G; Savader S; Farber S; Bittle PA; Tenorio L; Brueggemeyer CD; Tyson I
Clin Nucl Med; 1990 Jul; 15(7):480-4. PubMed ID: 2200626
[TBL] [Abstract][Full Text] [Related]
17. Study of renovascular hypertension in rats. III. Effects of converting enzyme inhibitor (captopril) on the plasma and renal renin activity in two-kidney goldblatt hypertension in rats.
Matsushita K
Tokai J Exp Clin Med; 1985 Oct; 10(5):545-9. PubMed ID: 3915608
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension and the arterial wall].
Rorive G; Carlier P; Foidart JM; van Cauwenberge H
Bull Mem Acad R Med Belg; 1981; 136(4):237-53. PubMed ID: 7030438
[No Abstract] [Full Text] [Related]
19. [Renal effects of captopril in hypertension with renal artery stenosis. Comparison between Tc-99m-DTPA scintigraphy and clearance method].
Chaignon M; Coutant V; Akerman M; Tainturier C; Lucsko M; Guedon J
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1205-9. PubMed ID: 2510650
[TBL] [Abstract][Full Text] [Related]
20. Captopril renal scintigraphy--an advance in the detection and treatment of renovascular hypertension.
Meier GH; Sumpio B; Black HR; Gusberg RJ
J Vasc Surg; 1990 Jun; 11(6):770-6; discussion 776-7. PubMed ID: 2101580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
